Targeting CD56 with an antibody–drug conjugate in Merkel cell carcinoma

Linked Article: Esnault et al. Br J Dermatol 2022; 186:295–306.

Saved in:
Bibliographic Details
Published inBritish journal of dermatology (1951) Vol. 186; no. 2; pp. 209 - 210
Main Authors Leiendecker, L., Jung, P.S., Obenauf, A.C.
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.02.2022
John Wiley and Sons Inc
Subjects
Biomarkers, Tumor
Carcinoma, Merkel Cell - drug therapy
Carcinoma, Merkel Cell - pathology
CD56 antigen
Commentaries
Humans
Immunoconjugates - therapeutic use
Skin cancer
Skin Neoplasms - drug therapy
Skin Neoplasms - pathology
Online AccessGet full text

Cover

More Information
Summary:Linked Article: Esnault et al. Br J Dermatol 2022; 186:295–306.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Commentary-3
content type line 23
Funding sources: This research was funded by the Vienna Science and Technology Fund #LS16‐063.
Conflicts of interest: the authors declare they have no conflicts of interest.
ISSN:0007-0963
1365-2133
DOI:10.1111/bjd.20894